NEWS SUMMARY: FCC. Markets kick off second half of August with drops Although no definitive peace agreement was expected to come from the talks between the US and the Ukraine-Europe delegation, stock markets took the opportunity for profit taking while rewarding defence companies in view of the possible “security guarantee” the US would offer Ukraine. In the STOXX 600, the sectors falling the most were Basic Materials and Autos, with Pharma (driven by Novo Nordisk) and Media rising the most. On...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: FCC Las bolsas empiezan la segunda quincena con caídas Aunque no se esperaba un acuerdo definitivo de Paz en las conversaciones entre EE.UU. y la delegación ucraniana-europea las bolsas aprovecharon para recoger beneficios mientras que premiaba a las empresas de defensa ante la posible “garantía de seguridad” que ofrecería Estados Unidos a Ucrania. En el STOXX 600 los sectores que más cayeron fueron R. Básicos y Autos frente a Farma (impulsada por N...
NEWS SUMMARY: N/A. Whether inflation will not rise or whether the Fed will be forced to cut rates in September is not so clear anymore The release of July’s industrial production prices, speeding up significantly more than expected, suggests that companies are indeed seeing the inflationary pressure from tariffs but not yet passed on to final prices, which could also have a negative impact on their margins in the 3Q’25. Following the data release, with weekly jobless claims also easing slightl...
COMPAÑÍAS QUE APARECEN EN EL INFORME: N/A Igual ya no está tan claro que la inflación no vaya a subir o que la Fed tenga que bajar tipos en septiembre La publicación del Precio de la Producción Industrial de julio en EE.UU., acelerándose sensiblemente más de lo esperado, apunta a que las empresas sí estarían sintiendo ya las presiones inflacionistas de los aranceles, pero que todavía no las han trasladado a los precios finales, lo que además podría incidir negativamente en sus márgenes en 3T’25...
NEWS SUMMARY: N/A. Greater expectations of rate cuts fuel stock markets Following the good inflation data released in the US, the Secretary of the Treasury, Scott Bessent, demanded new rate cuts of more than 150bps this year, starting with -50bps in September (R. Bostic, Fed member, stated he would see a -25bps cut appropriate in 2025 and thanks to the strength of the job market the Fed could still wait before cutting rates). Against this backdrop and in the absence of additional references, th...
NEWS SUMMARY: ACS. Ibex ended last week with daily gains Last week ended without relevant corporate results or macroeconomic data and with the implementation of tariff not entailing market volatility. The focus will now be on the US inflation (Tuesday) and peace talks in Ukraine between the US and Russia (Friday). The Ibex registered the best week in the past 4 months, ending above 14,800 points, returning to annual highs and near 2007 highs. Thus, in the STOXX 600 almost all sectors (16/20) en...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACS. EUROPA: VINCI. El Ibex cierra un pleno de subidas semanal Terminó la semana sin datos macro ni resultados empresariales de relevancia, y sin que la entrada en vigor de los aranceles trajera volatilidad a los mercados. Ahora toda la atención estará en la inflación en EE.UU. (martes) y las conversaciones de paz en Ucrania entre EE.UU. y Rusia (viernes). El Ibex cerró su mejor semana en 4 meses, renovando máximos anuales por encima de los 14.800 p...
NEWS SUMMARY: N/A. European markets ignore D. Trump D. Trump’s latest threats to the euro zone through higher tariffs did not have any impact on stock markets, which continued to climb as seen earlier this week, with the Ibex hitting again 2008 highs. Thus, in the STOXX 600 Energy and Real Estate saw the biggest gains vs. Pharma and Technology that were the worst performers. On the macro side, in the euro zone, June’s retail sales climbed more than expected. In Germany, June’s factory orders s...
A director at Sacyr S.A. sold 302,864 shares at 3.670EUR and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
2Q'25 vs. 2Q'24 Results Sales: € 2.375 Bn (+15.8% vs. +18.1% BS(e)); EBITDA: € 350.9 M (+38.7% vs. +43.4% BS(e)); 1H'25 vs. 1H'24 Results Sales: € 4.557 Bn (+7.5% vs. +8.7% BS(e)); EBITDA: € 675.3 M (+11.0% vs. +13.0% BS(e)); EBIT: € 254.5 M (-28.3% vs. +2.6% BS(e)); Net Profit: € 80.7 M (-71.1% vs. -52.0% BS(e));
Rdos. 2T'25 vs 2T'24: Ventas: 2.375 M euros (+15,8% vs +18,1% BS(e)); EBITDA: 350,9 M euros (+38,7% vs +43,4% BS(e)); Rdos. 1S'25 vs 1S'24: Ventas: 4.557 M euros (+7,5% vs +8,7% BS(e)); EBITDA: 675,3 M euros (+11,0% vs +13,0% BS(e)); EBIT: 254,5 M euros (-28,3% vs +2,6% BS(e)); BDI: 80,7 M euros (-71,1% vs -52,0% BS(e)).
2Q'25 vs. 2Q'24 Results Sales: € 12.318 Bn (+22.7% vs. +23.4% BS(e) and +18.4% consensus); EBITDA: € 735.0 M (+5.6% vs. +5.3% BS(e) and +5.7% consensus); EBIT: € 472.0 M (-1.7% vs. -2.6% BS(e) and +0.4% consensus); Net Profit: € 259.0 M (+8.4% vs. -20.7% BS(e) and -18.9% consensus); 1H'25 vs. 1H'24 Results Sales: € 24.108 Bn (+28.6% vs. +29.0% BS(e) and +26.3% consensus); EBITDA: € 1.434 Bn (+23.9% vs. +23.7% BS(e) and +24.0% consensus); EBIT: € 942.0 M (+16.7% vs. +16.2% BS(e) and +18.0% consen...
Rdos. 2T'25 vs 2T'24: Ventas: 12.318 M euros (+22,7% vs +23,4% BS(e) y +18,4% consenso); EBITDA: 735,0 M euros (+5,6% vs +5,3% BS(e) y +5,7% consenso); EBIT: 472,0 M euros (-1,7% vs -2,6% BS(e) y +0,4% consenso); BDI: 259,0 M euros (+8,4% vs -20,7% BS(e) y -18,9% consenso); Rdos. 1S'25 vs 1S'24: Ventas: 24.108 M euros (+28,6% vs +29,0% BS(e) y +26,3% consenso); EBITDA: 1.434 M euros (+23,9% vs +23,7% BS(e) y +24,0% consenso); EBIT: 942,0 M euros (+16,7% vs +16,2% BS(e) y +18,0% consenso); BDI: 4...
2Q'25 vs. 2Q'24 Results Sales: € 906.35 M (-2.1% vs. -1.7% BS(e)); EBITDA: € 57.4 M (+51.1% vs. +7.7% BS(e)); EBIT: € 27.45 M (+85.5% vs. +48.1% BS(e)); Net Profit: € -7.85 M (€ -29.5 M in 1H'24 vs. € -8.04 M BS(e)); 1H'25 vs. 1H'24 Results Sales: € 1.689 Bn (-1.8% vs. -1.6% BS(e)); EBITDA: € 84.1 M (+46.3% vs. +17.6% BS(e)); EBIT: € 46.25 M (+139.6% vs. +111.0% BS(e)); Net Profit: € -29.65 M (€ -34.2 M in 1H'24 vs. € -29.84 M BS(e));
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.